DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
down	IGKV3D-7; IGKV6D-21; IGKV1D-8; IGLV3-12; IGKV1OR2-108; IGKV1D-33; IGKV2D-24; TRAV2; IGKV3OR2-268; IGLV3-21; IGKV3-11; IGLV7-46; IGLV5-45; IGKV2-28; IGLV4-60; IGLV3-19; IGLV9-49; VPREB1; IGKV2D-28; IGLV2-14; IGKV6-21; IGKV1-33; IGKV1-39; IGLV5-37; IGKV1D-39; TRDV2; IGKV2D-40; IGKV3-7; IGKV1-9; IGKV2D-29; IGLV4-3; IGLV3-22; IGKV1D-13; IGLV4-69; IGKV2D-26; IGLV2-23; IGKV1D-16; IGKV2D-30; IGKV3-20; IGKV2-24; IGLV2-8; IGKV1-8; IGKV4-1; IGKV1-16; IGKV1D-17; IGLV3-16; IGLV6-57; IGLV2-11; IGKV3D-11; TRDV1; IGKV1-27; IGKV1-6; IGKV1-12; IGKV3D-15; IGKV5-2; IGKV1-17; IGLV1-40; IGKV1D-12; IGLV3-1; IGLV1-44; IGKV3D-20; IGKV1-5; IGLV3-25; IGKV1-13; IGLV8-61; IGLV2-18; IGLV1-36; IGLV7-43; IGLV3-9; IGLV3-27; IGLV1-51; IGKV2-30; IGKV2-29; TRDV3; IGKV6D-41; TRAV9-2; IGLV1-47; IGKV3-15; IGLV3-10; IGKV1D-43; IGLV5-48; IGLV10-54;	GO:0002377~immunoglobulin production	82	107	76.6355140186916	0	0	0	0	0	0	0
down	COLEC12; IGHV3-11; IGHV4-39; IGHV3-74; IGHV1-69; IGLL5; IGHG2; IGHV3-30; IGHV1-2; IGHV4-4; IGHV3-43; IGHV4-28; TRDC; IGLC6; IGHV3OR16-13; IGHV1-46; IGHV3-64; IGHV3-66; IGHV3-72; IGHV1-45; IGHV3OR15-7; IGHA2; IGHV1-3; IGHV1-18; IGHG4; IGHV3-15; IGHV3-49; IGHV1-69-2; IGHV3-20; IGHV3-21; IGLC7; IGLC3; IGHV3-23; IGHV3-13; IGHV2-70; IGHV3-53; IGHG3; IGHV3-7; IGHV1-58; IGHV4-61; IGLL1; IGHV2-5; IGHD; IGHV2-26; IGHV5-51; IGHV3-73; IGLC2; IGKC; IGHV6-1; IGHV4-31; IGHV3-48; IGHV1-24; IGHV4-59; IGHV4-34; IGHV3-33;	GO:0006910~phagocytosis, recognition	55	99	55.5555555555556	0	0	0	0	0	0	0
down	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; FCN1; C3; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; C1QA; C1QB; C1QC; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; IGLC6; IGLC2; IGLC3; IGHV1-2; IGLV3-21;	GO:0006956~complement activation	66	92	71.7391304347826	0	0	0	0	0	0	0
down	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; C3; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; C1QA; C1QB; C1QC; C4BPA; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; IGLC6; IGLC2; IGLC3; IGHV1-2; IGLV3-21; IGLL1; IGHV1-18; TRDC; IGHV3OR16-13; IGHV4-4; IGHV1-45; IGHV3-21; IGHV5-51; IGHV3-20; IGHD; IGHV1-24; IGHV1-69-2; IGHV3-49; IGHV4-61; IGHV3OR15-7; IGHV4-31; IGLL5; IGHV4-28; IGHV2-26; IGHV3-15; IGHV6-1; IGHV3-74; IGHV3-64; IGHV1-3; IGHV3-66; IGHV3-72; IGHA2; IGHV1-58; IGHV3-43; IGHV3-73;	GO:0006958~complement activation, classical pathway	96	161	59.6273291925466	0	0	0	0	0	0	0
down	TNFRSF13B; CCL25; LILRA1; CXCR1; KLRC1; CXCR3; CCR5; ADGRE1; LILRB2; CLEC1A; ADGRE3; CLEC1B; CLEC4A; TRBV24-1; TRBV6-4; TRBV19; TRBV6-6; TRBV5-1; TRBV6-1; TRBV27; TRBV5-5; TRBV3-1; TRBV2; TRBV13; TRBV28; TRBV6-2; TRBV11-1; TRBV7-2; TRBV4-1; TRBV29-1; TRBV15; TRBV10-2; TRBV4-2; TRBV20-1; TRBV12-5; TRBV12-4; TRBV5-6; TRBV5-4; TRBV9; TRBV12-3; TRBV18; TRBV7-9; TRBV11-2; TRBV10-3;	GO:0007166~cell surface receptor signaling pathway	44	268	16.4179104477612	0	0	0	0	0	0	0
down	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; C3; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; C1QA; C1QB; C1QC; C4BPA; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; IGLC6; IGLC2; IGLC3; CD19; IGHV1-2; IGLV3-21; CR1L;	GO:0030449~regulation of complement activation	68	113	60.1769911504425	0	0	0	0	0	0	0
down	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; IGLC6; IGLC2; IGLC3; FCGR2A; IGHV1-2; FCGR2B; NCKAP1L; IGLV3-21;	GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis	64	135	47.4074074074074	0	0	0	0	0	0	0
down	HP; ELANE; IRF8; CEBPE; COLEC12; TLR9; STAB1; SLAMF8; ADAMTS5; IGHV3-48; IGHV6-1; IGHG2; IGLC3; IGHV3OR15-7; IGHG3; IGHV1-46; IGHV3-53; IGHV3-13; IGLC6; IGHV1-24; IGHV3-73; IGHV1-2; IGHV3-30; IGLL1; IGHV1-45; IGHA2; IGLC2; IGHV3-72; IGLL5; IGHV2-5; IGHD; IGHV3-49; IGHV3OR16-13; IGHV3-74; IGHV1-18; IGHV2-70; IGHV3-7; IGHV1-58; IGHV4-34; IGHV3-15; IGHV5-51; IGHV3-66; IGHV3-64; IGHV3-23; IGHV1-69; IGHV1-69-2; IGHV4-31; IGLC7; TRDC; IGHV3-20; IGHV4-61; IGHV3-43; IGKC; IGHV4-39; IGHV4-28; IGHV2-26; IGHV4-4; IGHV3-21; IGHV3-11; IGHV4-59; IGHV1-3; IGHV3-33; IGHG4;	GO:0042742~defense response to bacterium	63	216	29.1666666666667	0	0	0	0	0	0	0
down	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; CD300LB; NCR3; TYROBP; LILRA1; NCR1; C3; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; TRBV12-3; TRAV8-4; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; TRBV7-9; CD1A; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; IGLC6; IGLC2; IGLC3; CD8B; CD19; IGHV1-2; KLRC1; CD1B; CD1C; FCGR2B; ICAM3; KIR2DL1; KIR2DL3; KIR3DL1; KIR3DL2; IGLV3-21; COLEC12; TREML2; CLEC4G; TREML4; CD300LD; LILRB2; LILRB1; CD300LF; KIR2DL4; CD300A; SIGLEC7; BTNL8; BTNL3; BTN1A1;	GO:0050776~regulation of immune response	93	216	43.0555555555556	0	0	0	0	0	0	0
down	MS4A1; CD19; MNDA; NCKAP1L; IGHV4-34; IGHV4-4; IGHV4-61; IGHV3-33; IGHV3-11; IGHV3-72; IGHV3-21; IGHV4-28; IGHV4-39; IGHV1-69-2; IGHV1-2; IGHV2-70; IGHV2-5; IGHV2-26; IGLL5; IGLC3; IGHV3-43; IGHV3-30; IGHV3-13; IGHV5-51; CD79B; IGHG2; IGHV3-23; IGHV1-3; IGHV1-69; IGHV3-73; IGHG4; IGHV1-46; IGLC6; IGLL1; IGHV4-59; IGHV3-64; IGHV6-1; IGHV1-45; IGHG3; IGHV1-18; IGHV1-24; IGLC7; IGHV3OR15-7; IGHA2; IGHV3-74; IGHV3-20; TRDC; IGHD; IGHV3-15; IGHV3-66; IGHV3-48; IGLC2; IGHV4-31; IGHV3OR16-13; IGHV1-58; IGHV3-53; IGHV3-49; IGHV3-7; IGKC;	GO:0050853~B cell receptor signaling pathway	59	125	47.2	0	0	0	0	0	0	0
down	TLR9; IGHV1-45; IGHV2-26; IGHV3-53; IGHG3; IGHV3-49; IGHV1-69-2; IGHG4; IGHV3OR15-7; IGLC7; IGLC3; IGHV3-15; IGHV4-39; IGHV3-64; IGHV4-28; IGHV2-70; IGHV3-21; IGHD; IGHV4-59; IGHV1-69; IGLL1; IGHV4-4; IGHV3-73; IGHV3-23; IGHV3-13; IGHV1-2; IGHV1-18; IGLL5; IGHV1-24; IGHV3-72; IGHV3-74; IGHV3-48; IGHV3-11; IGHG2; IGHV3-33; IGLC2; IGHV3-20; IGHV1-46; IGLC6; IGHV4-31; IGHV5-51; IGHV4-61; IGHV1-3; IGHV3OR16-13; IGHV6-1; IGHV4-34; IGHV3-66; IGHV1-58; IGHV3-7; IGHA2; TRDC; IGKC; IGHV3-30; IGHV3-43; IGHV2-5;	GO:0050871~positive regulation of B cell activation	55	98	56.1224489795918	0	0	0	0	0	0	0
down	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; JCHAIN; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHA2; GYPA; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; GYPB; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; CD48; IGLC6; IGLC2; IGLC3; VPREB1; IGLL1; MAG; IGHV1-2; CEACAM8; CEACAM3; IGLV3-21; ANGPT1; FOXJ1; SLC7A10; SIRPG;	GO:0050900~leukocyte migration	72	193	37.3056994818653	0	0	0	0	0	0	0
down	HBZ; HBD; HBG1; HBA1; HBM;	GO:0015671~oxygen transport	5	14	35.7142857142857	0.00015798609532058	0.00929923711067546	0.329401008743417	0.334772535984317	0.326241286837005	0.329243022648096	0.0765899225624163
down	IL12B; IL27; TLR9; TLR8; TLR7;	GO:0045078~positive regulation of interferon-gamma biosynthetic process	5	14	35.7142857142857	0.00015798609532058	0.00929923711067546	0.329401008743417	0.334772535984317	0.326241286837005	0.329243022648096	0.0765899225624163
down	CD1C; CD1A; CD1B; CD1E;	GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib	4	7	57.1428571428571	0.00018703826564925	0.010429844339757	0.389600707347394	0.396334084910767	0.377817296611491	0.389413669081745	0.0859017746093393
down	HP; GZMA; MT3; GZMK;	GO:0051354~negative regulation of oxidoreductase activity	4	7	57.1428571428571	0.00018703826564925	0.010429844339757	0.389600707347394	0.396334084910767	0.377817296611491	0.389413669081745	0.0859017746093393
down	TYROBP; FCGR2B; MNDA; CD300A; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	5	16	31.25	0.0002636250288962	0.0143236265700273	0.548603685133009	0.558621436231065	0.477371499765213	0.548603685133009	0.117971553661317
down	IL12B; XCL1; CD1B; CD1C; CD1E; CD1A;	GO:0001916~positive regulation of T cell mediated cytotoxicity	6	29	20.6896551724138	0.00043144912607062	0.0215496533342952	0.896551283974762	0.914240698143658	0.638113257458457	0.896551283974762	0.177486202413942
down	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.00043729829795879	0.0215496533342952	0.908268564860426	0.926635093374695	0.641953901403517	0.908268564860426	0.177486202413942
down	TLR9; TLR8; TLR7;	GO:0045356~positive regulation of interferon-alpha biosynthetic process	3	4	75	0.00074896128764745	0.0360692947392035	1	1	0.801825801339652	0.999988175417482	0.297072163885915
down	PF4; LTF; SEMG1; RNASE3; DEFA4; DEFA3; RNASE6; PF4V1;	GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide	8	62	12.9032258064516	0.00086131049116478	0.0405581540172926	1	1	0.841758848838961	0.999988175417482	0.334043087458533
down	LILRA5; ORM1; LPL; MMP8; LILRA2;	GO:1904469~positive regulation of tumor necrosis factor secretion	5	22	22.7272727272727	0.00090709997136595	0.0417857573766186	1	1	0.852673973083997	0.999988175417482	0.344153814296566
up	OR2A1; OR5K3; OR2W5; OR5B21; OR1F1; OR2J3; OR2A4; OR6A2; OR2H2; OR4E1; OR2T7; OR1E1; OR3A1; OR3A4P; OR1D4; OR3A3; OR4D2; OR1Q1; OR2B11; OR2G6; OR2T2; OR5AS1; OR6V1; OR2L5; OR2AK2; OR2L3; OR5AU1; OR4E2; OR6J1; OR11H7; OR11H4; OR10AD1; OR52B6; OR2D3; OR56A4; OR56B2P; OR52N4; OR56B1; OR52H1; OR52I1; OR1L6; OR1K1; OR5C1; OR1L4; OR1B1; OR1L8; OR1N1; OR1J1; OR2K2; OR9A1P; OR9A4; OR13D1; OR2T34; OR2L8; OR2AJ1; OR2T10; OR2T11; OR2T3; OR10AC1; OR2L2; OR52N5; OR52P1P; OR51Q1; OR52I2; OR1L3; OR1L1; OR2AE1; OR1F12; OR5K1; OR5K2; OR5B12; OR5B2; OR2A5; OR1F2P; OR52B2; OR2B2; OR2AG1; OR10A5; OR10A2; OR10A4; OR2D2; OR51M1; OR51J1; OR51I1; OR51I2; OR52D1; OR1A1; OR1A2; OR51B4; OR51B2;	GO:0050911~detection of chemical stimulus involved in sensory perception of smell	90	435	20.6896551724138	0.00101403098723429	1	1	1	1	1	1
down	LILRA5; ORM1; LPL; LILRA2; TLR8; NLRP7;	GO:0050718~positive regulation of interleukin-1 beta secretion	6	35	17.1428571428571	0.00103304483893529	0.0465749364617848	1	1	0.882357706891694	0.999988175417482	0.383598217198104
down	JCHAIN; IGKV3-20; IGHA2; XPNPEP3;	GO:0003094~glomerular filtration	4	13	30.7692307692308	0.00117599105067112	0.0519151049244189	1	1	0.916139939538997	0.999988175417482	0.427580651902761
down	CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	3	6	50	0.00172186679835862	0.0729727149144382	1	1	0.999988175417482	0.999988175417482	0.60101431095353
down	FCGR2B; TMEM176B; LILRB1;	GO:2001199~negative regulation of dendritic cell differentiation	3	6	50	0.00172186679835862	0.0729727149144382	1	1	0.999988175417482	0.999988175417482	0.60101431095353
down	ELANE; TLR8; TLR7; TLR9;	GO:0045416~positive regulation of interleukin-8 biosynthetic process	4	15	26.6666666666667	0.00182991042187863	0.0745688496915543	1	1	0.999988175417482	0.999988175417482	0.614160318257522
down	JCHAIN; IGKC; IGHG3; IGHA2; LTF; POTEE;	GO:0001895~retina homeostasis	6	40	15	0.00190662351059245	0.0762289663951964	1	1	0.999988175417482	0.999988175417482	0.627833290380209
down	C1QA; AZU1; AIF1; TLR8; TLR7;	GO:0001774~microglial cell activation	5	27	18.5185185185185	0.00201060991776258	0.0788978225136836	1	1	0.999988175417482	0.999988175417482	0.649814392809624
down	UPK3A; KCNA5; SLC12A3; SLC12A1;	GO:0055075~potassium ion homeostasis	4	16	25	0.00223596488483757	0.0850819400961285	1	1	0.999988175417482	0.999988175417482	0.700747720040585
down	HBA1; HBZ; HBD; HBM; HBG1;	GO:0042744~hydrogen peroxide catabolic process	5	28	17.8571428571429	0.00231445164527733	0.0850819400961285	1	1	0.999988175417482	0.999988175417482	0.700747720040585
down	IL12B; NLRP6; GPR17;	GO:0002862~negative regulation of inflammatory response to antigenic stimulus	3	7	42.8571428571429	0.00240761505749787	0.0850819400961285	1	1	0.999988175417482	0.999988175417482	0.700747720040585
down	FCGR2B; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	3	7	42.8571428571429	0.00240761505749787	0.0850819400961285	1	1	0.999988175417482	0.999988175417482	0.700747720040585
down	CCL25; AZU1; CCR5; CXCR5; CXCR3; CXCR1; CCR2; CCR8;	GO:0060326~cell chemotaxis	8	74	10.8108108108108	0.00240911581206593	0.0850819400961285	1	1	0.999988175417482	0.999988175417482	0.700747720040585
down	TRPM2; CXCR1; CCR2; CCR5;	GO:0002407~dendritic cell chemotaxis	4	17	23.5294117647059	0.00270004485096698	0.0922805651483713	1	1	0.999988175417482	0.999988175417482	0.760036684150792
down	XCL1; NCKAP1L; XCL2; CXCR1; PF4; CCL25; CCL23; PF4V1;	GO:0030593~neutrophil chemotaxis	8	76	10.5263157894737	0.00280346437316847	0.0942943016943491	1	1	0.999988175417482	0.999988175417482	0.776622122749889
down	FOLR2; CCR2; CCL23; CCL25; XCL2; XCL1;	GO:0002548~monocyte chemotaxis	6	44	13.6363636363636	0.00293676474258842	0.0963692874607374	1	1	0.999988175417482	0.999988175417482	0.793712019187022
down	HP; HBZ; HBD; GSTA1; HBG1; HBA1; HBM; LOXHD1;	GO:0098869~cellular oxidant detoxification	8	77	10.3896103896104	0.00301861646086754	0.0963692874607374	1	1	0.999988175417482	0.999988175417482	0.793712019187022
down	MYL3; MYBPH; MYBPC3;	GO:0006942~regulation of striated muscle contraction	3	8	37.5	0.00324033135442137	0.0963692874607374	1	1	0.999988175417482	0.999988175417482	0.793712019187022
down	TLR9; TLR8; TLR7;	GO:0045359~positive regulation of interferon-beta biosynthetic process	3	8	37.5	0.00324033135442137	0.0963692874607374	1	1	0.999988175417482	0.999988175417482	0.793712019187022
down	LTF; DEFA4; DEFA3;	GO:0051673~membrane disruption in other organism	3	8	37.5	0.00324033135442137	0.0963692874607374	1	1	0.999988175417482	0.999988175417482	0.793712019187022
down	C1QA; C1QB; C1QC;	GO:0098883~synapse pruning	3	8	37.5	0.00324033135442137	0.0963692874607374	1	1	0.999988175417482	0.999988175417482	0.793712019187022
down	ELANE; CCR2; FUT7;	GO:1903238~positive regulation of leukocyte tethering or rolling	3	8	37.5	0.00324033135442137	0.0963692874607374	1	1	0.999988175417482	0.999988175417482	0.793712019187022
down	LILRA5; LPL; OSM; FABP4; IL12B; CCR2; TLR9; TLR7;	GO:0050729~positive regulation of inflammatory response	8	78	10.2564102564103	0.00324639496509493	0.0963692874607374	1	1	0.999988175417482	0.999988175417482	0.793712019187022
down	SPTA1; HLA-DMB; IL12B; AIF1; NCKAP1L; LILRB2; CD209;	GO:0042102~positive regulation of T cell proliferation	7	61	11.4754098360656	0.00327446375515483	0.0963692874607374	1	1	0.999988175417482	0.999988175417482	0.793712019187022
down	LTF; RNASE3; DEFA3; DEFA4;	GO:0002227~innate immune response in mucosa	4	19	21.0526315789474	0.00381766942950212	0.110817007138562	1	1	0.999988175417482	0.999988175417482	0.912705622442686
down	LY86; SCIMP; CD180;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	3	9	33.3333333333333	0.00422904237017396	0.120419884529573	1	1	0.999988175417482	0.999988175417482	0.991796372253719
down	GPR55; LPAR4; GPR17; GPR65; F2RL3;	GO:0035025~positive regulation of Rho protein signal transduction	5	33	15.1515151515152	0.00435195226953511	0.120419884529573	1	1	0.999988175417482	0.999988175417482	0.991796372253719
down	RAMP3; PF4; ADRA2A; GPR65; ADGRE1; ADGRE3; PTGFR; PTGDR; RXFP2;	GO:0007189~adenylate cyclase-activating G protein-coupled receptor signaling pathway	9	103	8.7378640776699	0.00494763826160283	0.124810065194481	1	1	0.999988175417482	0.999988175417482	1
down	FCRL3; TLR9; SLAMF8;	GO:0045577~regulation of B cell differentiation	3	10	30	0.00538162626623828	0.132600768118127	1	1	0.999988175417482	0.999988175417482	1
down	CLEC12B; LILRB1; KIR2DL4;	GO:0045953~negative regulation of natural killer cell mediated cytotoxicity	3	10	30	0.00538162626623828	0.132600768118127	1	1	0.999988175417482	0.999988175417482	1
down	ELANE; CTSG; IFNL1;	GO:0050778~positive regulation of immune response	3	11	27.2727272727273	0.00670488551544968	0.158120225211856	1	1	0.999988175417482	0.999988175417482	1
down	TRPM2; TRPV5; FAM155B;	GO:0098703~calcium ion import across plasma membrane	3	11	27.2727272727273	0.00670488551544968	0.158120225211856	1	1	0.999988175417482	0.999988175417482	1
down	MMP8; SCIMP; LILRB2; TLR9; TLR8; TLR7;	GO:0032755~positive regulation of interleukin-6 production	6	53	11.3207547169811	0.00670674713374164	0.158120225211856	1	1	0.999988175417482	0.999988175417482	1
down	LILRA5; LPL; AIF1; LILRA2; TLR8;	GO:2000778~positive regulation of interleukin-6 secretion	5	37	13.5135135135135	0.00671581890942285	0.158120225211856	1	1	0.999988175417482	0.999988175417482	1
down	PF4; CXCR5; CNR2; PF4V1;	GO:0030595~leukocyte chemotaxis	4	24	16.6666666666667	0.00788457335187309	0.165419910223951	1	1	0.999988175417482	0.999988175417482	1
down	PF4; IL12B; IRF8; BATF;	GO:0042832~defense response to protozoan	4	24	16.6666666666667	0.00788457335187309	0.165419910223951	1	1	0.999988175417482	0.999988175417482	1
down	LPAR4; GPR65; GPR17; F2RL3; GPR55;	GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway	5	39	12.8205128205128	0.00818233798695256	0.168792053471974	1	1	0.999988175417482	0.999988175417482	1
down	LTF; GATA1; TMEM119;	GO:0033690~positive regulation of osteoblast proliferation	3	12	25	0.00820461609608936	0.168792053471974	1	1	0.999988175417482	0.999988175417482	1
down	CEACAM4; ICAM3; IRF8; CEBPE; PLD4; ELANE;	GO:0006909~phagocytosis	6	57	10.5263157894737	0.00919006620178053	0.187247598861278	1	1	0.999988175417482	0.999988175417482	1
down	CD19; FCGR2B; TLR8;	GO:0016064~immunoglobulin mediated immune response	3	13	23.0769230769231	0.00988567320900025	0.197932348263087	1	1	0.999988175417482	0.999988175417482	1
down	LTF; MS4A1; CCR2; FOXJ1; JCHAIN; AIRE;	GO:0006959~humoral immune response	6	58	10.3448275862069	0.009901287831943	0.197932348263087	1	1	0.999988175417482	0.999988175417482	1
down	IL12B; FASLG; AIF1; IRF8; CCL23; XCL1; XCL2; CCL25;	GO:0071346~cellular response to interferon-gamma	8	96	8.33333333333333	0.0100880399696093	0.197945248352153	1	1	0.999988175417482	0.999988175417482	1
down	IL12B; IRF8; SCIMP; TLR9;	GO:0032735~positive regulation of interleukin-12 production	4	26	15.3846153846154	0.0100887620679719	0.197945248352153	1	1	0.999988175417482	0.999988175417482	1
down	FFAR3; ADRA2A; HTR1B; OPRD1; RXFP2; P2RY12;	GO:0007193~adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	6	59	10.1694915254237	0.0106507776134427	0.202472705368828	1	1	0.999988175417482	0.999988175417482	1
down	OPRD1; FFAR4; F2RL3; P2RY12; NMUR1; GPR33;	GO:0007200~phospholipase C-activating G protein-coupled receptor signaling pathway	6	60	10	0.0114395658315845	0.202472705368828	1	1	0.999988175417482	0.999988175417482	1
down	MMP8; IL12B; FCGR2B;	GO:0032693~negative regulation of interleukin-10 production	3	14	21.4285714285714	0.0117520336714627	0.202472705368828	1	1	0.999988175417482	0.999988175417482	1
down	HBZ; EPB42; TAL1;	GO:0043249~erythrocyte maturation	3	14	21.4285714285714	0.0117520336714627	0.202472705368828	1	1	0.999988175417482	0.999988175417482	1
down	ADRA2A; LILRB2; LILRB1;	GO:0051926~negative regulation of calcium ion transport	3	14	21.4285714285714	0.0117520336714627	0.202472705368828	1	1	0.999988175417482	0.999988175417482	1
down	UPK3A; SLC12A3; SLC12A1;	GO:0055078~sodium ion homeostasis	3	14	21.4285714285714	0.0117520336714627	0.202472705368828	1	1	0.999988175417482	0.999988175417482	1
down	CLEC4G; LILRB2; LILRB1; FOXJ1; PLA2G2D;	GO:0042130~negative regulation of T cell proliferation	5	43	11.6279069767442	0.0117527809156989	0.202472705368828	1	1	0.999988175417482	0.999988175417482	1
down	CTSG; DEFA4; DEFA3; CLEC6A;	GO:0050832~defense response to fungus	4	28	14.2857142857143	0.0126568485141905	0.212856047631505	1	1	0.999988175417482	0.999988175417482	1
down	RCVRN; OPRD1; P2RX1; P2RY12;	GO:0051924~regulation of calcium ion transport	4	28	14.2857142857143	0.0126568485141905	0.212856047631505	1	1	0.999988175417482	0.999988175417482	1
down	KCNA5; KCNQ1; KCNE1B;	GO:0097623~potassium ion export across plasma membrane	3	15	20	0.0138068551351285	0.22627205834815	1	1	0.999988175417482	0.999988175417482	1
down	CACNA1H; KCNA5; GRIK3; KCNH7; GABRD; HTR3B; HTR3A; CHRFAM7A;	GO:0042391~regulation of membrane potential	8	102	7.84313725490196	0.0138411667431525	0.22627205834815	1	1	0.999988175417482	0.999988175417482	1
down	ORM1; BPI; NCKAP1L; TLR9;	GO:0032715~negative regulation of interleukin-6 production	4	29	13.7931034482759	0.014083386013382	0.22627205834815	1	1	0.999988175417482	0.999988175417482	1
down	PCDH8; HES7; DLL3; MESP2; MESP1;	GO:0001756~somitogenesis	5	46	10.8695652173913	0.0150377557870542	0.22627205834815	1	1	0.999988175417482	0.999988175417482	1
down	CACNA1H; ADRA2A; AIF1; RAMP3; AVPR1A;	GO:0032870~cellular response to hormone stimulus	5	46	10.8695652173913	0.0150377557870542	0.22627205834815	1	1	0.999988175417482	0.999988175417482	1
down	C1QB; KCNQ1; ROR1; TIFAB; CYTL1;	GO:0048839~inner ear development	5	46	10.8695652173913	0.0150377557870542	0.22627205834815	1	1	0.999988175417482	0.999988175417482	1
down	CCR2; XCL1; XCL2;	GO:0010820~positive regulation of T cell chemotaxis	3	16	18.75	0.0160525322688851	0.229833215390322	1	1	0.999988175417482	0.999988175417482	1
down	TLR9; TLR8; TLR7;	GO:0034162~toll-like receptor 9 signaling pathway	3	16	18.75	0.0160525322688851	0.229833215390322	1	1	0.999988175417482	0.999988175417482	1
down	LTF; BTNL3; BTN1A1; BTNL8;	GO:0001817~regulation of cytokine production	4	31	12.9032258064516	0.017232003286467	0.243430766426824	1	1	0.999988175417482	0.999988175417482	1
down	AVPR1A; P2RY12; NMUR1; GPR55;	GO:0007202~activation of phospholipase C activity	4	31	12.9032258064516	0.017232003286467	0.243430766426824	1	1	0.999988175417482	0.999988175417482	1
down	GATA1; NCKAP1L; RHAG;	GO:0048821~erythrocyte development	3	17	17.6470588235294	0.018490750042518	0.258202943220998	1	1	0.999988175417482	0.999988175417482	1
down	NXPH4; POMC; NMUR1; PROK2; PYY; SSTR3; CYSLTR2; OPRD1;	GO:0007218~neuropeptide signaling pathway	8	108	7.40740740740741	0.0185214003631863	0.258202943220998	1	1	0.999988175417482	0.999988175417482	1
down	POMC; ORM1; BPI; LILRA4; CLEC4A;	GO:0032720~negative regulation of tumor necrosis factor production	5	49	10.2040816326531	0.0188855921014082	0.261559278842378	1	1	0.999988175417482	0.999988175417482	1
down	FCER2; KCNA5; MESP2; MESP1; HES7; NEUROD4; HEYL; DLL3;	GO:0007219~Notch signaling pathway	8	109	7.3394495412844	0.0193992500111768	0.263531799302893	1	1	0.999988175417482	0.999988175417482	1
down	CACNA1H; DES; CYP2J2; KCNQ1;	GO:0008016~regulation of heart contraction	4	33	12.1212121212121	0.0207867139604025	0.265343655916223	1	1	0.999988175417482	0.999988175417482	1
down	XCL2; CCL23; CCL25; XCL1;	GO:0048247~lymphocyte chemotaxis	4	33	12.1212121212121	0.0207867139604025	0.265343655916223	1	1	0.999988175417482	0.999988175417482	1
down	SPI1; BATF; BATF3;	GO:0043011~myeloid dendritic cell differentiation	3	18	16.6666666666667	0.0211225342411334	0.266420536053343	1	1	0.999988175417482	0.999988175417482	1
down	RNASE2; RNASE3; RNASE6;	GO:0090501~RNA phosphodiester bond hydrolysis	3	18	16.6666666666667	0.0211225342411334	0.266420536053343	1	1	0.999988175417482	0.999988175417482	1
down	RAMP3; HP; MT3; HBA1;	GO:0010942~positive regulation of cell death	4	34	11.7647058823529	0.0227202153358692	0.283200801745334	1	1	0.999988175417482	0.999988175417482	1
down	AQP1; SLC12A3; SLC12A1;	GO:0006884~cell volume homeostasis	3	19	15.7894736842105	0.0239482993342499	0.291578047578147	1	1	0.999988175417482	0.999988175417482	1
down	GATA1; TAL1; CLEC1B;	GO:0030220~platelet formation	3	19	15.7894736842105	0.0239482993342499	0.291578047578147	1	1	0.999988175417482	0.999988175417482	1
down	FFAR3; TLR9; TLR7;	GO:0032722~positive regulation of chemokine production	3	19	15.7894736842105	0.0239482993342499	0.291578047578147	1	1	0.999988175417482	0.999988175417482	1
down	CD300LD; IDO2; CD300LF; IRF8;	GO:0002376~immune system process	4	35	11.4285714285714	0.0247595279894355	0.291578047578147	1	1	0.999988175417482	0.999988175417482	1
down	LTF; SEMG1; DEFA4; DEFA3;	GO:0031640~killing of cells of other organism	4	35	11.4285714285714	0.0247595279894355	0.291578047578147	1	1	0.999988175417482	0.999988175417482	1
down	GABRD; GRIK3; GRIK4; RGS7BP;	GO:0060078~regulation of postsynaptic membrane potential	4	35	11.4285714285714	0.0247595279894355	0.291578047578147	1	1	0.999988175417482	0.999988175417482	1
down	SPTA1; TAL1; FLT3; CCR2; ANGPT1;	GO:0030097~hemopoiesis	5	53	9.43396226415094	0.0249481608796741	0.291578047578147	1	1	0.999988175417482	0.999988175417482	1
down	TUBB8; RXFP2; DAZL;	GO:0001556~oocyte maturation	3	20	15	0.02696789381993	0.299188308923726	1	1	0.999988175417482	0.999988175417482	1
down	NEFH; NCKAP1L; PARVG;	GO:0030031~cell projection assembly	3	20	15	0.02696789381993	0.299188308923726	1	1	0.999988175417482	0.999988175417482	1
down	CCL23; XCL1; XCL2;	GO:0048245~eosinophil chemotaxis	3	20	15	0.02696789381993	0.299188308923726	1	1	0.999988175417482	0.999988175417482	1
down	CTNNA2; FANCD2; SHANK1;	GO:0048854~brain morphogenesis	3	20	15	0.02696789381993	0.299188308923726	1	1	0.999988175417482	0.999988175417482	1
down	RAMP3; TRPM2; CCR5; CACNG6; NMUR1; TRPV5;	GO:0006816~calcium ion transport	6	74	8.10810810810811	0.027137231002607	0.299498919242314	1	1	0.999988175417482	0.999988175417482	1
down	NCKAP1L; TNFRSF13B; GAPT;	GO:0001782~B cell homeostasis	3	21	14.2857142857143	0.0301806431578273	0.3151197254058	1	1	0.999988175417482	0.999988175417482	1
down	TYROBP; AZU1; CCR2;	GO:0042535~positive regulation of tumor necrosis factor biosynthetic process	3	21	14.2857142857143	0.0301806431578273	0.3151197254058	1	1	0.999988175417482	0.999988175417482	1
down	FCGR2B; TREML2; TREML4;	GO:0045088~regulation of innate immune response	3	21	14.2857142857143	0.0301806431578273	0.3151197254058	1	1	0.999988175417482	0.999988175417482	1
down	CD8B; SLA; FLT4; SHC2; LTK; FLT3; FGFR4; ROR1;	GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway	8	120	6.66666666666667	0.0310839935259458	0.3151197254058	1	1	0.999988175417482	0.999988175417482	1
down	MYL3; DES; MYBPC2; MYBPC3;	GO:0030049~muscle filament sliding	4	38	10.5263157894737	0.0315222249409269	0.3151197254058	1	1	0.999988175417482	0.999988175417482	1
down	NCR3; NCR1; IL12B;	GO:0030101~natural killer cell activation	3	22	13.6363636363636	0.0335853904008491	0.3151197254058	1	1	0.999988175417482	0.999988175417482	1
down	CRHBP; MT3; HTR1B; KCNQ1; SLAMF8;	GO:0035690~cellular response to drug	5	59	8.47457627118644	0.0361637636622346	0.3151197254058	1	1	0.999988175417482	0.999988175417482	1
down	SPTA1; BAIAP2L2; OTOF;	GO:0007009~plasma membrane organization	3	23	13.0434782608696	0.037180534631138	0.3151197254058	1	1	0.999988175417482	0.999988175417482	1
down	TRPM2; AZU1; PTGFR;	GO:0035584~calcium-mediated signaling using intracellular calcium source	3	23	13.0434782608696	0.037180534631138	0.3151197254058	1	1	0.999988175417482	0.999988175417482	1
down	ELANE; ADRA2A; FLT3; PIK3R6; PIK3R5;	GO:0043406~positive regulation of MAP kinase activity	5	60	8.33333333333333	0.0382898458330901	0.3151197254058	1	1	0.999988175417482	0.999988175417482	1
down	LIM2; UNC45B; CRYGN; CRYBB1;	GO:0002088~lens development in camera-type eye	4	41	9.75609756097561	0.0392659434178171	0.3151197254058	1	1	0.999988175417482	0.999988175417482	1
down	CA4; AQP1; HBA1; RHAG;	GO:0015701~bicarbonate transport	4	42	9.52380952380952	0.0420667965937036	0.3151197254058	1	1	0.999988175417482	0.999988175417482	1
down	RNASE2; RNASE3; RNASE6;	GO:0006401~RNA catabolic process	3	25	12	0.0449336065748747	0.3151197254058	1	1	0.999988175417482	0.999988175417482	1
down	IL12B; XCL1; TLR9;	GO:0032733~positive regulation of interleukin-10 production	3	25	12	0.0449336065748747	0.3151197254058	1	1	0.999988175417482	0.999988175417482	1
down	MMP8; COL15A1; COL19A1; MMP23B;	GO:0030574~collagen catabolic process	4	43	9.30232558139535	0.0449775261679536	0.3151197254058	1	1	0.999988175417482	0.999988175417482	1
up	S100A8; S100A9; SLC30A8;	GO:0032119~sequestering of zinc ion	3	4	75	0.0456525967204975	1	1	1	1	1	1
down	UGT2B17; CYP2E1; SULT1A3; UGT2B28;	GO:0008202~steroid metabolic process	4	44	9.09090909090909	0.0479979575546963	0.3151197254058	1	1	0.999988175417482	0.999988175417482	1
